Home › Funds › Millennium Management › ENGN
Millennium Management position in ENGN
ENGENE THERAPEUTICS INC · Health Care
Latest position (Q2 2026)69.00K sh
Reported value held$20.00K
Portfolio Weight0.00%
First reportedQ2 2025
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 13.03K | $47.43K | New |
| Q3 2025 | 20.50K | $140.03K | Add |
| Q4 2025 | 1.50M | $13.54M | Add |
| Q1 2026 | 959.68K | $6.54M | Reduce |
| Q2 2026 | 69.00K | $20.00K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ENGN
- Balyasny Asset Management 1.01M sh · $1.74M · Q2 2026
- Renaissance Technologies 829.70K sh · $1.44M · Q2 2026
- UBS Group AG 509.09K sh · $880.72K · Q2 2026
- Two Sigma Investments 164.57K sh · $284.71K · Q2 2026
- Morgan Stanley 33.09K sh · $57.24K · Q2 2026
- Citadel Advisors 30.80K sh · $53.28K · Q2 2026
- D. E. Shaw & Co 104.62K sh · $30.33K · Q2 2026
- Point72 Asset Management 13.99K sh · $24.21K · Q2 2026
- Wells Fargo & Co 6.84K sh · $11.83K · Q2 2026